Benzodiazurqlscn300ngml
This test checks whether benzodiazepine medications are present in your urine sample.
{"Detects the presence of benzodiazepine drugs in urine","Used to monitor medication compliance or detect drug misuse","Results are reported as positive if level exceeds 300 ng/mL","A positive result means benzodiazepines were found in your urine","False positives can occur with certain medications or supplements"}
Key facts at a glance
- LOINC
- 70142-5
- Short code
- BENZ-U
- Synonyms
- Benzodiaz Ur Ql Scn>300 ng/mL
- Category
- chemistry
- Sample
- urine
- Container
- Sterile, leak-proof urine collection container without preservative (plastic screw-cap cup); for forensic/medico-legal testing, use tamper-evident chain-of-custody container.
- Units
- N/A
- Ref high
- 300
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- screen-ng-ml
- CPT
- 80307
- SNOMED
- 250515002
- Specimen volume
- 30-50 mL of random urine
- Stability
- Refrigerated (2-8°C): up to 7 days. Frozen (-20°C or below): up to 30 days for confirmatory testing. Room temperature: up to 24-48 hours depending on preservative.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 1–24 hours
- Order
- routine
What is this test?
The Benzodiazepines Urine Screening Test is a laboratory test that detects whether benzodiazepine medications are present in your urine. Benzodiazepines are prescription drugs commonly used to treat anxiety, insomnia, seizures, and muscle spasms. Common examples include diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin). This test uses a screening method with a cutoff value of 300 ng/mL, meaning the test looks for benzodiazepine levels above this threshold.
Reference range
Negative (cutoff: >300 ng/mL). Result reported as positive when benzodiazepine concentration exceeds 300 ng/mL screening threshold.N/A
No fasting required. Patient should be informed that benzodiazepine use (prescribed or otherwise) may affect results. Collect sample under appropriate chain-of-custody procedures if required for medico-legal or employment-related testing.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test is primarily used for medication compliance monitoring to ensure patients are taking their prescribed benzodiazepines as directed by their healthcare provider. It may also be used in substance abuse evaluation, pain management programs, or pre-employment screening. A positive result indicates that benzodiazepines were detected in the urine at a concentration above 300 ng/mL. It's important to note that this is a screening test, and positive results may be confirmed with more specific testing methods if needed. The presence of benzodiazepines in urine can typically be detected for several days after last use, depending on the specific medication and individual factors such as metabolism and kidney function.
Frequently asked questions
Why do I need this test?
How is the sample collected?
What do the results mean?
Can medications or supplements affect the results?
How long do benzodiazepines stay detectable in urine?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy